These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 20579805

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM, Lai C, Nuyten DS, Halfwerk H, Kristel P, van Beers E, Joosse SA, Klijn C, Nederlof PM, Reinders MJ, Wessels LF, van de Vijver MJ.
    Clin Cancer Res; 2010 Jan 15; 16(2):651-63. PubMed ID: 20068109
    [Abstract] [Full Text] [Related]

  • 25. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE, Tibshirani R, Børresen-Dale AL, Pollack JR.
    Genes Chromosomes Cancer; 2006 Nov 15; 45(11):1033-40. PubMed ID: 16897746
    [Abstract] [Full Text] [Related]

  • 26. National Oncology Forum: perspectives for the year 2000.
    DeVita VT, Bleickardt EW.
    Cancer J; 2001 Nov 15; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [Abstract] [Full Text] [Related]

  • 27. Combining gene expression signatures and autoantibody profiles in human meningioma.
    Keller A, Ludwig N, Comtesse N, Henn W, Steudel WI, Lenhof HP, Meese E.
    Gene Ther; 2009 Feb 15; 16(2):184-9. PubMed ID: 18701916
    [Abstract] [Full Text] [Related]

  • 28. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
    Miller LD, Liu ET.
    Breast Cancer Res; 2007 Feb 15; 9(2):206. PubMed ID: 17397520
    [Abstract] [Full Text] [Related]

  • 29. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.
    Zentralbl Gynakol; 2006 Apr 15; 128(2):76-81. PubMed ID: 16673249
    [Abstract] [Full Text] [Related]

  • 30. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
    Iorio MV, Casalini P, Tagliabue E, Ménard S, Croce CM.
    Eur J Cancer; 2008 Dec 15; 44(18):2753-9. PubMed ID: 19022662
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM, Green AR, Powe DG, Ellis IO.
    J Clin Pathol; 2009 May 15; 62(5):422-8. PubMed ID: 19398594
    [Abstract] [Full Text] [Related]

  • 32. Prognostic applications of gene expression signatures in breast cancer.
    Normanno N, De Luca A, Carotenuto P, Lamura L, Oliva I, D'Alessio A.
    Oncology; 2009 May 15; 77 Suppl 1():2-8. PubMed ID: 20130425
    [Abstract] [Full Text] [Related]

  • 33. Gene expression profiling of human cancers.
    Bucca G, Carruba G, Saetta A, Muti P, Castagnetta L, Smith CP.
    Ann N Y Acad Sci; 2004 Dec 15; 1028():28-37. PubMed ID: 15650229
    [Abstract] [Full Text] [Related]

  • 34. Methods for microRNA microarray profiling.
    Ranade AR, Weiss GJ.
    Methods Mol Biol; 2011 Dec 15; 700():145-52. PubMed ID: 21204032
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA profiling in cancer.
    Munker R, Calin GA.
    Clin Sci (Lond); 2011 Aug 15; 121(4):141-58. PubMed ID: 21526983
    [Abstract] [Full Text] [Related]

  • 36. [Gene expression profiling in cancer research].
    Michiels S, Koscielny S, Boulet T, Hill C.
    Bull Cancer; 2007 Nov 15; 94(11):976-80. PubMed ID: 18055315
    [Abstract] [Full Text] [Related]

  • 37. MicroRNA expression profiling for molecular classification of pediatric brain tumors.
    Sredni ST, Huang CC, Bonaldo Mde F, Tomita T.
    Pediatr Blood Cancer; 2011 Jul 15; 57(1):183-4. PubMed ID: 21425446
    [No Abstract] [Full Text] [Related]

  • 38. Profiles in variation: lung carcinogenesis.
    Carbone DP.
    Cancer Prev Res (Phila); 2009 Aug 15; 2(8):695-7. PubMed ID: 19638487
    [Abstract] [Full Text] [Related]

  • 39. Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types.
    Starmans MH, Krishnapuram B, Steck H, Horlings H, Nuyten DS, van de Vijver MJ, Seigneuric R, Buffa FM, Harris AL, Wouters BG, Lambin P.
    Br J Cancer; 2008 Dec 02; 99(11):1884-90. PubMed ID: 18985037
    [Abstract] [Full Text] [Related]

  • 40. Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy.
    Baehner FL, Lee M, Demeure MJ, Bussey KJ, Kiefer JA, Barrett MT.
    J Surg Oncol; 2011 May 01; 103(6):563-73. PubMed ID: 21480251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.